Autism rare diseases Q BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder Subtype By Staff Reports 3 years ago Q BioMed Inc., a commercial stage biotechnology acceleration company, today announced advancements on several fronts
Autism genes Prenatal vitamin intake may reduce autism recurrence in high-risk families By Staff Reports 3 years ago High-risk younger siblings of children with autism are less likely to be diagnosed with autism
Autism Cognitive Enhancement Therapy Improves Outcomes for Adults with Autism By Staff Reports 4 years ago New collaborative research out of the University of Pittsburgh School of Social Work and the
Autism Boston University’s Dr. Helen Tager-Flusberg to Join Q BioMed’s Advisory Committee By Staff Reports 4 years ago Q BioMed Inc., a biotechnology acceleration company, announced today that Dr. Helen Tager-Flusberg from Boston